Published by Josh White on 2nd February 2024
(Sharecast News) - Hutchmed China announced on Friday that Inmagene Biopharmaceuticals has exercised options to licence two drug candidates, IMG-007 and IMG-004, as part of their strategic partnership.
URL: http://www.digitallook.com/dl/news/story/34066402/...